Vraylar 1.5 MG capsule 30S
Ended Awarded Last action
- Contract number
- SPE2DR26F5Y3P
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $10,994
Award facts
- Contract value 100% obligated
- $10,994.01 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency issued a delivery order to Amerisourcebergen Drug Corp on March 23, 2026, for Vraylar 1.5 mg capsules (30-count), with a ceiling value of $10,994.01.
The order is issued under the DLA Troop Support Medical IDC (SPE2DX), a comprehensive global pharmaceutical supply vehicle valued at up to $999,999,999.00 through December 2026. Place of performance is Conshohocken, PA. The order was priced as firm fixed price with no set-aside applied. Ultimate completion date is March 24, 2026.
Quick answers
Who was awarded contract SPE2DR26F5Y3P?
SPE2DR26F5Y3P was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on March 23, 2026.
How much is contract SPE2DR26F5Y3P worth?
The government has obligated $10,994 on SPE2DR26F5Y3P.
Is contract SPE2DR26F5Y3P an order under another contract?
Yes. SPE2DR26F5Y3P is a delivery order under SPE2DR25D3404, an indefinite delivery contract.
Was contract SPE2DR26F5Y3P competed?
The extent of competition for SPE2DR26F5Y3P was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award